Search Results - "OKAZAKI, Taku"
-
1
PD-1 and PD-1 ligands: from discovery to clinical application
Published in International immunology (01-07-2007)“…Programmed cell death-1 (PD-1, Pdcd1), an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting…”
Get full text
Journal Article -
2
Restriction of PD-1 function by cis -PD-L1/CD80 interactions is required for optimal T cell responses
Published in Science (American Association for the Advancement of Science) (10-05-2019)“…Targeted blockade of PD-1 with immune checkpoint inhibitors can activate T cells to destroy tumors. PD-1 is believed to function mainly at the effector, but…”
Get full text
Journal Article -
3
LAG-3: from molecular functions to clinical applications
Published in Journal for immunotherapy of cancer (01-09-2020)“…To prevent the destruction of tissues owing to excessive and/or inappropriate immune responses, immune cells are under strict check by various regulatory…”
Get full text
Journal Article -
4
The PD-1–PD-L pathway in immunological tolerance
Published in Trends in Immunology (01-04-2006)“…Since the first observation of spontaneous autoimmune diseases in programmed cell death 1 (PD-1) knockout mice, PD-1 has been postulated to have essential…”
Get full text
Journal Article -
5
PD-1 deficiency results in the development of fatal myocarditis in MRL mice
Published in International immunology (01-06-2010)“…The deficiency of programmed cell death 1 (PD-1, Pdcd1), a negative immuno-receptor belonging to the CD28/cytotoxic T lymphocyte antigen 4 (CTLA-4) family, can…”
Get full text
Journal Article -
6
PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation
Published in Frontiers in immunology (29-03-2019)“…Cancer-immunotherapy targeting programmed cell death 1 (PD-1) activates tumor-specific T cells and provides clinical benefits in various cancers. However, the…”
Get full text
Journal Article -
7
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
Published in Cancer (01-04-2010)“…BACKGROUND: Melanoma tends to be refractory to various immunotherapies because of tumor‐induced immunosuppression. To investigate the mechanism underlining the…”
Get full text
Journal Article -
8
PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity
Published in Nature immunology (01-03-2022)“…Targeted blockade of the checkpoint molecule programmed cell death 1 (PD-1) can activate tumor-specific T cells to destroy tumors, whereas targeted…”
Get full text
Journal Article -
9
A battle between two biological singularities: Immune response vs. cancer
Published in Biophysics and Physicobiology (01-01-2024)“…In a post-growth multicellular organism, the phenomenon in which a small number of rare cells can be the starting point for inducing a dramatic change in the…”
Get full text
Journal Article -
10
T-cell-intrinsic and -extrinsic regulation of PD-1 function
Published in International immunology (01-12-2021)“…Abstract Cancer immunotherapies that target PD-1 (programmed cell death 1) aim to destroy tumors by activating tumor-specific T cells that are otherwise…”
Get full text
Journal Article -
11
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8⁺ T lymphocytes are prognostic factors of human ovarian cancer
Published in Proceedings of the National Academy of Sciences - PNAS (27-02-2007)“…The ligands for programmed cell death 1 (PD-1), an immunoinhibitory receptor belonging to CD28/cytotoxic T lymphocyte antigen 4 family, are PD-1 ligand 1 and 2…”
Get full text
Journal Article -
12
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
Published in The Journal of experimental medicine (14-02-2011)“…Stimulatory and inhibitory co-receptors play fundamental roles in the regulation of the immune system. We describe a new mouse model of spontaneous autoimmune…”
Get full text
Journal Article -
13
Involvement of PD-L1 on Tumor Cells in the Escape from Host Immune System and Tumor Immunotherapy by PD-L1 Blockade
Published in Proceedings of the National Academy of Sciences - PNAS (17-09-2002)“…PD-1 is a receptor of the Ig superfamily that negatively regulates T cell antigen receptor signaling by interacting with the specific ligands (PD-L) and is…”
Get full text
Journal Article -
14
PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
Published in Proceedings of the National Academy of Sciences - PNAS (26-02-2008)“…Signaling through the programmed death 1 (PD-1) inhibitory receptor upon binding its ligand, PD-L1, suppresses immune responses against autoantigens and tumors…”
Get full text
Journal Article -
15
Establishment of NOD-Pdcd1-/-Mice as an Efficient Animal Model of Type I Diabetes
Published in Proceedings of the National Academy of Sciences - PNAS (16-08-2005)“…Mice deficient in programmed cell death 1 (PD-1, Pdcd1), an immunoinhibitory receptor belonging to the CD28/cytotoxic T lymphocyte-associated antigen-4 family,…”
Get full text
Journal Article -
16
Intestinal CX3C chemokine receptor 1high (CX3CR1high) myeloid cells prevent T-cell-dependent colitis
Published in Proceedings of the National Academy of Sciences - PNAS (27-03-2012)“…Adequate activation of CD4+ T lymphocytes is essential for host defense against invading pathogens; however, exaggerated activity of effector CD4+ T cells…”
Get full text
Journal Article -
17
PD-1 Immunoreceptor Inhibits B Cell Receptor-Mediated Signaling by Recruiting Src Homology 2-Domain-Containing Tyrosine Phosphatase 2 to Phosphotyrosine
Published in Proceedings of the National Academy of Sciences - PNAS (20-11-2001)“…PD-1 is an immunoreceptor that belongs to the immunoglobulin (Ig) superfamily and contains two tyrosine residues in the cytoplasmic region. Studies on…”
Get full text
Journal Article -
18
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
Published in Nature medicine (01-12-2003)“…We recently reported that mice deficient in the programmed cell death-1 (PD-1) immunoinhibitory coreceptor develop autoimmune dilated cardiomyopathy (DCM),…”
Get full text
Journal Article -
19
PD-1 inhibits antiviral immunity at the effector phase in the liver
Published in The Journal of experimental medicine (07-07-2003)“…Unlike naive T cells, effector T cells can be activated by either T cell receptor signal or costimulatory signal alone and therefore the absence of…”
Get full text
Journal Article -
20
New regulatory co-receptors: inducible co-stimulator and PD-1
Published in Current Opinion in Immunology (01-12-2002)“…Autoreactive lymphocytes are suppressed in healthy individuals by so-called peripheral tolerance. Accumulating evidence indicates that co-receptor signaling…”
Get full text
Book Review Journal Article